Profil
Lisa A.
Michaels worked as the Head of Rare Disease, Cell & Gene Therapy at Bayer Pharmaceuticals Corp.
She then worked as the Chief Medical Officer & Executive Vice President at Editas Medicine, Inc. from 2020 to 2022.
Michaels holds a doctorate degree from the University of Virginia.
Anciens postes connus de Lisa A. Michaels
| Sociétés | Poste | Fin |
|---|---|---|
| EDITAS MEDICINE, INC. | Chief Tech/Sci/R&D Officer | 07/02/2022 |
| Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | 01/11/2020 |
Formation de Lisa A. Michaels
| University of Virginia | Doctorate Degree |
Expériences
Fonctions occupées
Relations
11
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EDITAS MEDICINE, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Bayer Pharmaceuticals Corp. |
